These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 2214148
21. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW. Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225 [Abstract] [Full Text] [Related]
22. [The clinical value of tissue polypeptide antigen in ovarian carcinoma]. Wu L, Sun J, Wang X. Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428 [Abstract] [Full Text] [Related]
27. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma. Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A. Anticancer Res; 1994 Feb; 14(6B):2743-6. PubMed ID: 7532929 [Abstract] [Full Text] [Related]
29. Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients. Salman T, el-Ahmady O, Tony O, Darwish M. Anticancer Res; 1997 Feb; 17(4B):3083-6. PubMed ID: 9329607 [Abstract] [Full Text] [Related]
38. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer]. Nishida O, Shiroto H, Satoh N, Nakajima Y, Manabe K, Kondoh Y, Sano F, Uchino J. Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515 [Abstract] [Full Text] [Related]